| 1 |
24525728 | Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer. | 2014 Feb 13 |
1 |
| 2 |
25139025 | Co-administration of ABT-737 and SAHA induces apoptosis, mediated by Noxa upregulation, Bax activation and mitochondrial dysfunction in PTEN-intact malignant human glioma cell lines. | 2014 Dec |
1 |
| 3 |
23344663 | Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis. | 2013 Apr |
2 |
| 4 |
23429261 | pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737. | 2013 May |
2 |
| 5 |
23814486 | PAX3-FOXO1 induces up-regulation of Noxa sensitizing alveolar rhabdomyosarcoma cells to apoptosis. | 2013 Jul |
1 |
| 6 |
22173547 | Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737. | 2012 Feb 1 |
1 |
| 7 |
21897876 | The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53. | 2011 |
3 |
| 8 |
20576107 | Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1. | 2010 Jun 24 |
3 |
| 9 |
20732961 | Actinomycin D decreases Mcl-1 expression and acts synergistically with ABT-737 against small cell lung cancer cell lines. | 2010 Sep 1 |
1 |
| 10 |
18987671 | BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis. | 2009 Apr |
2 |
| 11 |
19246337 | ABT-737 synergizes with chemotherapy to kill head and neck squamous cell carcinoma cells via a Noxa-mediated pathway. | 2009 May |
1 |
| 12 |
19412422 | Endogenous Noxa Determines the Strong Proapoptotic Synergism of the BH3-Mimetic ABT-737 with Chemotherapeutic Agents in Human Melanoma Cells. | 2009 May |
1 |
| 13 |
19088028 | Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2/Bcl-xL inhibitor, ABT-737. | 2008 Dec 15 |
3 |